• Marc Hämel’s insights in MassMEDIC’s annual DDD report

    March 25, 2021

    Read our CEO interview in the MassMedic in partnership with Alira Health

  • Holistic device selection and user-experience innovation to drive differenciation

    March 22, 2021

    The latest issue of ‘On Drug Delivery’ is highlighted the challenges involved in the selection of drug devices for…

  • International Women’s Day 2021 – #choosetochallenge

    March 8, 2021

    Celebrating our leaders, not with a rose, but with a voice.

    An equal world is an empowered world. At Nemera, each individual is unique with a unique story and we celebrate them all. The International Women’s day marks a call to action for accelerating women’s equality giving us the perfect opportunity to celebrate.

    Our colleagues across the globe share their thoughts on supporting women empowerment and women who inspire them or have contributed to who they are! We are proud of our diversity that enables us to solve problems, innovate, achieve good business outcomes and therefore positively impact patients’ lives.

  • Nemera expands diabetes device portfolio and prepares for the future

    March 1, 2021

    The latest issue of ‘Pharmaceutical Post’ is highlighted diabetes device portfolio and the evolution

  • Nemera is committed to Gender Equality

    February 26, 2021

    The Gender Equality Index 2020 has well improved. As of 2019, Nemera shared its overall ambitions with its staff…

  • The right route to take: the smart device that can help manage drug overdosing

    February 19, 2021

    The latest issue of ‘EPM’ is highlighted Safe’n’Spray, the smart device that can help manage drug overdosing

  • Nemera’s holistic approach to dermal drug delivery

    January 26, 2021

    The latest issue of ‘Skin Drug Delivery’ is highlighted Nemera’s holistic approach in dermal pharmaceutical application.

  • A new statistical method to assess in vitro bioequivalence of nasal products

    January 20, 2021

    This article presents the so called Between-Batch Bioequivalence (BBE) method, evaluated through both simulation and real-case (Nasonex® & Flonase®)…

  • Safe’n’Sound®: Protection against needlestick injuries

    January 6, 2021

    The latest issue of ‘Harro Höfliger’ is highlighted Safe’n’Sound, our parenteral passive safety device. Read more…

  • Our preservative-free ophthalmic device is highlighted in ‘The Pharmaceutical Post’ magazine

    December 17, 2020

    The latest issue of ‘The Pharmaceutical Post’ is highlighting Ophthalmic Preservative-free devices. Read more…